Global Health (MEDANTA) Share Price Falls for Second Straight Session
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Global Health Share Price has now fallen for the second straight session, with the cumulative move across the streak at -4.16% from Rs 1,358.05. The latest Global Health Share Price stood at Rs 1,301.50, and according to Univest data, the price pattern is confirmed but no company-specific cause is established. For readers tracking Global Health Share Price today, the key point is that the decline has extended beyond one session.
Global Health Share Price is moving with a market capitalisation of Rs 36,514.54 crore, which places the company in the large-cap category. A two-session fall is more informative than a single-day decline because it shows the lower price has held across consecutive trading days, not just within one intraday move. That makes the Global Health Share Price fall a pattern worth following alongside valuation and sector context.
Global Health (MEDANTA) Share Price Fall Streak: Consecutive Decline Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,301.5 |
| Previous Close | Rs 1,331.7 |
| Today's Move | -Rs 30.20 (-2.27%) |
| Open | Rs 1,334 |
| High | Rs 1,342.95 |
| Low | Rs 1,299.5 |
| Market Capitalisation | Rs 36,514.54 crore |
Global Health Share Price today opened at Rs 1,334, touched a high of Rs 1,342.95 and a low of Rs 1,299.5 before last trading at Rs 1,301.50. Against the previous close of Rs 1,331.7, the stock was down Rs 30.2 or 2.27%. The intraday range shows that the Global Health Share Price moved lower after the open and stayed near the day’s lower band for much of the session.
The market capitalisation of Rs 36,514.54 crore keeps Global Health Share Price in the large-cap category. The current quote is also below the streak start base price of Rs 1,358.05, which reinforces that this is a two-session slide rather than a one-off move. For investors reading Global Health Share Price today, the relevant comparison is not just the percentage fall but the way the lower close followed the prior session. That sets up the fundamental view next.
What the Consecutive Declines Show
The two-session pattern in Global Health Share Price shows a cumulative decline of 4.16% from Rs 1,358.05. The first lower close set the base for the streak, and the second straight session kept the stock beneath that level. For a reader, the useful takeaway is that Global Health Share Price has not merely reacted within one day; it has remained under pressure across a short run of trading days.
That matters because consecutive declines can change how investors read Global Health Share Price news and stock analysis. The move is still best understood through the verified numbers: a lower current price, a lower close than the previous day, and a streak that now spans two sessions. Univest figures confirm the price action, but they do not point to a specific company trigger.
Global Health (MEDANTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 36,514.54 crore |
| P/E Ratio | 64.38x |
| P/B Ratio | 8.71x |
| ROE | 15.12% |
| ROCE | 19.38% |
| EPS | Rs 20.69 |
| Book Value Per Share | Rs 152.94 |
| Dividend Yield | 0.04% |
Global Health (MEDANTA) fundamental metrics show P/E 64.38x, P/B 8.71x, ROE 15.12%, ROCE 19.38%. Taken on their own, these numbers offer context rather than a trading signal.
Global Health has a market capitalisation of Rs 36,514.54 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 64.38x, P/B at 8.71x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.12% and ROCE of 19.38%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.69, book value per share of Rs 152.94, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 44.75x, median ROE of 13.01%, median ROCE of 15.84%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 64.38x |
| Benchmark Median P/E | 44.75x |
| Benchmark Average P/E | 97.08x |
| Benchmark P/E Range | 6.78x to 1,588.84x |
| Company P/B Ratio | 8.71x |
| Benchmark Median P/B | 3.92x |
| Benchmark Average P/B | 4.53x |
| Company ROE | 15.12% |
| Benchmark Median ROE | 13.01% |
| Benchmark Average ROE | 12.87% |
| Company ROCE | 19.38% |
| Benchmark Median ROCE | 15.84% |
| Benchmark Average ROCE | 2.83% |
| Company Market Capitalisation | Rs 36,514.54 crore |
| Benchmark Median Market Cap | Rs 555.31 crore |
| Benchmark Average Market Cap | Rs 10,799.96 crore |
Global Health (MEDANTA) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.
Global Health (MEDANTA) has a P/E ratio of 64.38x, which is above the benchmark median of 44.75x, a difference of +43.87%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Global Health (MEDANTA) has a ROE of 15.12%, which is above the benchmark median of 13.01%, a difference of +16.22%. Global Health (MEDANTA) has a ROCE of 19.38%, which is above the benchmark median of 15.84%, a difference of +22.35%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,16,695.63 | 55.12 | 11.89 | 23.54 | 21.73 |
| Max Healthcare Institute | MAXHEALTH | 91,963.22 | 61.23 | 8.16 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 91,517.37 | 98.37 | 4.81 | 12.95 | 13.93 |
| Aster DM Healthcare | ASTERDM | 61,779.78 | 189.01 | 14.24 | 13.07 | 16.22 |
| Fortis Healthcare | FORTIS | 59,332.16 | 55.11 | 5.68 | 11.32 | 14.07 |
Global Health (MEDANTA) has a P/E ratio of 64.38x compared with the displayed peer median of 61.23x. The comparison is relative and should not be read as a recommendation. Its ROE of 15.12% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 19.38% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Global Health (MEDANTA) has a market capitalisation of Rs 36,514.54 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Global Health
- Global Health Share Price has now marked a second straight session of decline, making the streak itself the main event to track.
- The current Global Health Share Price sits below the prior close, the day open and the streak start base price.
- Global Health Share Price still carries a P/E of 64.38 and P/B of 8.71, so valuation remains part of the discussion.
- ROE of 15.12% and ROCE of 19.38% give context to the business quality behind the lower price.
- Global Health Share Price also needs to be read against the Healthcare sector median and peer multiples.
About Global Health
Global Health operates in the Hospital & Healthcare Services industry within Healthcare. The business context that matters for Global Health Share Price is that it is a large hospital network name rather than a diversified industrial company. Investors follow the stock for its healthcare operating model, its return ratios and its valuation compared with other listed hospital chains.
For Global Health Share Price analysis, the important business lens is straightforward: the company earns from hospital and healthcare services, and its market value reflects that operating platform. In this streak, the business profile helps readers interpret why the stock is being compared with other healthcare providers rather than broader market names.
Track Global Health Share Price on Univest
Use Global Health (MEDANTA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Global Health Share Price on Univest for live price updates, key financial ratios, 52-week levels and market insights. The same page also helps readers follow Global Health Share Price today alongside valuation, sector context and peer comparison in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Global Health Share Price falling today?
Ans. Global Health Share Price is lower because it has now fallen for the second straight session, with the latest close at Rs 1,301.50. According to Univest data, the price pattern is confirmed, but no company-specific cause is established.
What is Global Health Share Price today?
Ans. Global Health Share Price last traded at Rs 1,301.50, down Rs 30.2 or 2.27% from the previous close. The stock also traded between Rs 1,299.5 and Rs 1,342.95 during the day.
How much has Global Health Share Price fallen in the streak?
Ans. Global Health Share Price has fallen 4.16% across the second straight session streak, starting from Rs 1,358.05. That cumulative decline is the key context for reading the move beyond one session.
What is the market capitalisation of Global Health ?
Ans. Global Health has a market capitalisation of Rs 36,514.54 crore, which places it in the large-cap category. That scale helps frame Global Health Share Price against the Healthcare sector and listed hospital peers.
What valuation does Global Health Share Price trade at?
Ans. Global Health Share Price corresponds to a P/E of 64.38 and a P/B of 8.71. EPS stands at Rs 20.69 and book value per share at Rs 152.94, so the valuation remains elevated versus many sector peers.
How do ROE and ROCE support Global Health Share Price analysis?
Ans. Global Health reports ROE of 15.12% and ROCE of 19.38%. Those figures place the company above the sector median on both measures and help explain why the lower price is being read alongside quality metrics.
How does Global Health compare with healthcare peers?
Ans. Global Health Share Price sits between lower-priced peers such as Fortis on one side and higher-multiple names such as Manipal Health and Aster DM on the other. Its market cap is also close to Narayana Hrudayalaya.
What should investors watch next in Global Health Share Price?
Ans. Investors should watch whether Global Health Share Price stays below the streak base and how it trades relative to the Healthcare benchmark. The current price, valuation multiples and return ratios are the main verified markers.
